The effect of the general anti-avoidance rule on corporate tax avoidance in China
MetadataShow full item record
© 2018 Elsevier Ltd This study examines the effect of the general anti-avoidance rule (GAAR), introduced on January 1, 2008, to enforce corporate tax avoidance laws in China. Based on a sample of 517 Chinese firms over the 2006–2010 period (2585 firm-years), we find a reduction in tax avoidance following the implementation of the GAAR that appears to be the result of the new and stringent tax legislation and the consolidation of Chinese tax law. We also observe that the effects of firms’ engaging a Big Four auditor and directors with tax expertise in deterring tax avoidance significantly decreased following implementation of the GAAR. To all intents and purposes, it seems that the implementation of the GAAR in China has moderated the effects of and substituted for these particular monitoring and disciplining mechanisms.
Showing items related by title, author, creator and subject.
The effect of approach/avoidance training on alcohol consumption is mediated by change in alcohol action tendencySharbanee, Jason; Hu, L.; Stritzke, W.; Wiers, R.; Rinck, M.; MacLeod, C. (2014)Training people to respond to alcohol images by making avoidance joystick movements can affect subsequent alcohol consumption, and has shown initial efficacy as a treatment adjunct. However, the mechanisms that underlie ...
Self-Monitoring vs. Implementation Intentions: a Comparison of Behaviour Change Techniques to Improve Sleep Hygiene and Sleep Outcomes in StudentsMairs, L.; Mullan, Barbara (2015)© 2015, International Society of Behavioral Medicine. Purpose: This study seeks to investigate and compare the efficacy of self-monitoring and implementation intentions—two post-intentional behaviour change techniques—for ...
Non-prescription medicines and Australian community pharmacy interventions: rates and clinical significanceWilliams, K.; Emmerton, Lynne; Taylor, R.; Werner, J.; Benrimoj, S. (2011)Objective: To quantify pharmacy intervention rates for non-prescription medications (pharmacist-only and pharmacy medicines), to document the clinical significance of these interventions and to determine the adverse health ...